Posted in Thomson 158 Reuters Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters Estimated read time 7 min read Posted on October 1, 2024 by admin Kena Betancur | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter,…
